Fabien Moncaubeig came to Pall Life Sciences through the ATMI acquisition in 2014 and prior to ATMI was one of the first employees of Artelis. In 2015 he was named head of Cell Culture Technologies. In this role he is responsible for the Europe, Middle East and Asia bioprocess service groups. With his team, they work on optimization and industrialization of cell culture and downstream processes both within Pall’s lab capabilities and through consulting services at customer site. He has extensive experience with vaccine, viral vector and stem cell productions, as well as managing internal and external bioreactor-centered projects. Moncaubeig holds a masters degree in biotechnology from ENSTBB Bordeaux INP.